Dobutamine

Specifications

34368-04-2CAS Number

112-679-1EC Number

4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diolIUPAC Name

C18H23NO3Chemical Formula

301.4 g/molMolecular Weight

dobutamine; 34368-04-2; DL-dobutamine; Dobutamina; racemic-Dobutamine; Dobutaminum; Racemic dobutamine; rac-dobutamine; Compound 81929; 4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol; DTXSID3022958; 4-(2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)benzene-1,2-diol; COMPOUND-81929; (+-)-4-(2-((3-(p-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol; CHEBI:4670; DTXCID702958; 3S12J47372; 3,4-dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine; 4-{2-[3-(4-Hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol; 1,2-Benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, (+-)-; 4-(2-(4-(4-hydroxyphenyl)butan-2-ylamino)ethyl)benzene-1,2-diol; 3,4-dihydroxy-N-(3-(4-hydroxyphenyl)-1-methylpropyl)-beta-phenylethylamine; 4-(2-((4-(4-Hydroxyphenyl)butan-2-yl)amino)ethyl)benzene-1,2-diol; 4-(2-(3-(4-Hydroxy-phenyl)-1-methyl-propylamino)-ethyl)-benzene-1,2-diol; Dobutamin ratiopharm; Tartrate, Dobutamine; Hydrobromide, Dobutamine; Lactobionate, Dobutamine; RefChem:56520; C01CA07; 112-679-1; CHEMBL926; MFCD00072085; Dobutaminum [INN-Latin]; Dobutamina [INN-Spanish]; Dobutamine [USAN]; NCGC00015321-04; 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-1,2-benzenediol; (+/-)-4-(2-((3-(p-hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol; 4-[2-[[3-(4-hydroxyphenyl)-1-methyl-propyl]amino]ethyl]benzene-1,2-diol; CAS-34368-04-2; (+/-)-dobutamine; LY 81929; 4-(2-((3-(4-HYDROXYPHENYL)-1-METHYLPROPYL)AMINO)ETHYL)-1,2-BENZENEDIOL; Dobutamine [USAN:USP:INN:BAN]; UNII-3S12J47372; 1,2-BENZENEDIOL, 4-(2-((3-(4-HYDROXYPHENYL)-1-METHYLPROPYL)AMINO)ETHYL)-; DOBUTAMINE [MI]; DOBUTAMINE [INN]; Dobutamine (USAN/INN); Prestwick0_000352; Prestwick1_000352; Prestwick2_000352; Prestwick3_000352; DOBUTAMINE [VANDF]; DOBUTAMINE [WHO-DD]; Lopac0_000365; SCHEMBL21237; BSPBio_000443; GTPL535; cid_36811; SPBio_002364; BPBio1_000489; orb1689351; SCHEMBL29929447; DOBUTAMINE [USP IMPURITY]; HMS2089K05; Tox21_110126; BDBM50325274; EBC-26536; EX-A15354; HY-15746A; STL373008; 4-(2-{[3-(4-hydroxyphenyl)-1-methylpropyl]amino}ethyl)benzene-1,2-diol; AKOS025248013; Tox21_110126_1; CCG-204460; DB00841; FR72007; SDCCGSBI-0050353.P002; NCGC00015321-03; NCGC00015321-05; NCGC00015321-06; NCGC00015321-07; NCGC00015321-08; NCGC00015321-09; NCGC00015321-11; NCGC00015321-18; NCGC00024629-02; NCGC00024629-03; SY373107; VS-12236; CS-0013581; NS00007916; C06967; D03879; T60677; EN300-18539446; L001157; Q422782; SR-01000075265-9; BRD-A78322124-003-03-3; BRD-A78322124-003-14-0; BRD-A78322124-003-15-7; 4-[2-[[4-(4-Hydroxyphenyl)-2-butyl]amino]ethyl]benzene-1,2-diol; 4-(2-([3-(4-Hydroxyphenyl)-1-methylpropyl]amino)ethyl)-1,2-benzenediol #; (.+/-.)-4-[2-[[3-(p-Hydroxyphenyl)-1-methylpropyl]amino]ethyl]pyrocatechol; 1,2-Benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, (.+/-.)-; 4-{2-[3-(4-Hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol(Dobutamine); 1,2-BENZENEDIOL, 4-(2-((3-(4-HYDROXYPHENYL)-1-METHYLPROPYL)AMINO)ETHYL)-, (+/-)-Synonyms